Similar articles

• Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis: Erratum.

  [No authors listed] [No authors listed] Medicine (Baltimore). 2018 Jan;97(4):e9727. doi: 10.1097/MD.0000000000009727. Medicine (Baltimore). 2018. PMID: 29369210 Free PMC article. No abstract available.
• The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?

  Ou Q, Cheng J, Zhang L, Wang H, Wang W, Ma Y. Ou Q, et al. Tumour Biol. 2017 Jun;39(6):1010428317706214. doi: 10.1177/1010428317706214. Tumour Biol. 2017. PMID: 28653873
• Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.

  Xiong Y, Zhao N, Zheng Y, Wang J, Wei F, Ren X. Xiong Y, et al. Tumour Biol. 2017 Jun;39(6):1010428317701639. doi: 10.1177/1010428317701639. Tumour Biol. 2017. PMID: 28618954
• Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.

  Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H. Zhao Z, et al. Arch Gynecol Obstet. 2018 Apr;297(4):849-857. doi: 10.1007/s00404-018-4678-8. Epub 2018 Jan 24. Arch Gynecol Obstet. 2018. PMID: 29368160 Review.
• The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer.

  Chen L, Kong X, Yan C, Fang Y, Wang J. Chen L, et al. Onco Targets Ther. 2020 Feb 14;13:1397-1412. doi: 10.2147/OTT.S227171. eCollection 2020. Onco Targets Ther. 2020. PMID: 32104003 Free PMC article. Review.